Biosyent Inc (BIOYF)
7.49
-0.13
(-1.71%)
USD |
OTCM |
Jun 28, 16:00
Biosyent Price: 7.49 for June 28, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 28, 2024 | 7.49 | 7.49 | 7.49 | 7.49 | 131.00 |
| Jun 27, 2024 | 7.62 | 7.62 | 7.62 | 7.62 | 0.000 |
| Jun 26, 2024 | 7.76 | 7.76 | 7.61 | 7.62 | 1250.00 |
| Jun 25, 2024 | 7.59 | 7.59 | 7.502 | 7.502 | 1593.00 |
| Jun 24, 2024 | 7.72 | 7.73 | 7.62 | 7.62 | 2165.00 |
| Jun 21, 2024 | 7.35 | 7.35 | 7.35 | 7.35 | 300.00 |
| Jun 20, 2024 | 6.97 | 7.19 | 6.97 | 7.19 | 606.00 |
| Jun 18, 2024 | 6.95 | 7.05 | 6.95 | 7.05 | 475.00 |
| Jun 17, 2024 | 7.20 | 7.20 | 6.93 | 6.93 | 370.00 |
| Jun 14, 2024 | 7.28 | 7.28 | 7.00 | 7.00 | 6876.00 |
| Jun 13, 2024 | 6.85 | 6.85 | 6.80 | 6.80 | 724.00 |
| Jun 12, 2024 | 6.85 | 6.85 | 6.85 | 6.85 | 100.00 |
| Jun 11, 2024 | 6.69 | 6.69 | 6.69 | 6.69 | 155.00 |
| Jun 10, 2024 | 6.69 | 6.69 | 6.69 | 6.69 | 0.000 |
| Jun 07, 2024 | 6.69 | 6.69 | 6.69 | 6.69 | 368.00 |
| Jun 06, 2024 | 6.68 | 6.68 | 6.68 | 6.68 | 100.00 |
| Jun 05, 2024 | 6.665 | 6.665 | 6.665 | 6.665 | 0.000 |
| Jun 04, 2024 | 6.665 | 6.665 | 6.665 | 6.665 | 0.000 |
| Jun 03, 2024 | 6.680 | 6.680 | 6.665 | 6.665 | 1340.00 |
| May 31, 2024 | 6.65 | 6.66 | 6.65 | 6.66 | 1420.00 |
| May 30, 2024 | 6.62 | 6.636 | 6.62 | 6.636 | 1741.00 |
| May 29, 2024 | 6.62 | 6.662 | 6.62 | 6.62 | 7009.00 |
| May 28, 2024 | 6.691 | 6.96 | 6.59 | 6.96 | 3323.00 |
| May 24, 2024 | 6.66 | 6.70 | 6.59 | 6.59 | 4368.00 |
| May 23, 2024 | 6.570 | 6.570 | 6.51 | 6.55 | 4681.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.150
Minimum
Mar 18 2020
7.89
Maximum
Apr 13 2022
5.591
Average
5.71
Median
Nov 17 2021
Price Benchmarks
| Acasti Pharma Inc | 2.92 |
| Aurinia Pharmaceuticals Inc | 5.69 |
| Edesa Biotech Inc | 4.28 |
| Lexaria Bioscience Corp | 2.786 |
| Xenon Pharmaceuticals Inc | 39.07 |
Price Related Metrics
| PE Ratio | 17.23 |
| PS Ratio | 3.709 |
| PEG Ratio | 0.4082 |
| Price to Book Value | 3.393 |
| Price to Free Cash Flow | 17.37 |
| Earnings Yield | 5.80% |
| Market Cap | 86.77M |
| PEGY Ratio | 0.3927 |
| Operating PE Ratio | 14.89 |
| Normalized PE Ratio | 17.21 |